当前位置： SCI文献检索 > ONCOGENE期刊下所有文献 > Vimentin is a novel AKT1 target mediating motility and invasion.

Vimentin is a novel AKT1 target mediating motility and invasion.

Abstract：

:The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.

journal_name

Oncogene

journal_title

Oncogene

authors

Zhu QS,Rosenblatt K,Huang KL,Lahat G,Brobey R,Bolshakov S,Nguyen T,Ding Z,Belousov R,Bill K,Luo X,Lazar A,Dicker A,Mills GB,Hung MC,Lev D

doi

10.1038/onc.2010.421

subject

Has Abstract

pub_date

2011-01-27 00:00:00

pages

457-70

issue

4

eissn

0950-9232

issn

1476-5594

pii

onc2010421

journal_volume

30

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: implications in targeting therapy.

    abstract：:Mutations in epidermal growth factor receptor (EGFR) kinase domain associate with clinical responses to EGFR inhibitors and are frequently observed in non-small cell lung cancer (NSCLC) patients in East Asian populations. Clinically identified EGFR mutations cause constitutive receptor activation. The activating mecha...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210684

    authors： Fu YN,Yeh CL,Cheng HH,Yang CH,Tsai SF,Huang SF,Chen YR

    更新日期：2008-02-07 00:00:00

  • Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.

    abstract：:The forkhead transcription factor FOXO1, a downstream target of phosphatidylinositol-3-kinase/Akt signalling pathway, regulates cyclic differentiation and apoptosis in normal endometrium, but its role in endometrial carcinogenesis is unknown. Screening of endometrial cancer cell lines demonstrated that FOXO1 is expres...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210626

    authors： Goto T,Takano M,Albergaria A,Briese J,Pomeranz KM,Cloke B,Fusi L,Feroze-Zaidi F,Maywald N,Sajin M,Dina RE,Ishihara O,Takeda S,Lam EW,Bamberger AM,Ghaem-Maghami S,Brosens JJ

    更新日期：2008-01-03 00:00:00

  • Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells.

    abstract：:Low dose treatment with the DNA methylation inhibitor decitabine has been shown to be applicable for the management of certain types of cancer. However, its antitumor effect and mechanisms are context dependent and its activity has never been systematically studied in bladder cancer treatment. We used mouse models, cu...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-019-0799-1

    authors： Wu M,Sheng L,Cheng M,Zhang H,Jiang Y,Lin S,Liang Y,Zhu F,Liu Z,Zhang Y,Zhang X,Gao Q,Chen D,Li J,Li Y

    更新日期：2019-07-01 00:00:00

  • DNA double strand break repair and chromosomal translocation: lessons from animal models.

    abstract：:The maintenance of genomic stability is one of the most important defenses against neoplastic transformation. This objective must be accomplished despite a constant barrage of spontaneous DNA double strand breaks. These dangerous lesions are corrected by two primary pathways of double strand break repair; non homologo...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/sj.onc.1204767

    authors： Ferguson DO,Alt FW

    更新日期：2001-09-10 00:00:00

  • Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma.

    abstract：:Adult T-cell leukemia/lymphoma (ATL) is an aggressive T-cell neoplasm. While ATL cells in peripheral blood (PB-ATL) are sensitive to anti-CC chemokine receptor 4 treatment, non-PB-ATLs, including lymph node ATLs (LN-ATLs), are more aggressive and resistant. We examined characteristic cytokines and growth factors that ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-020-01393-x

    authors： Totani H,Shinjo K,Suzuki M,Katsushima K,Mase S,Masaki A,Ito A,Ri M,Kusumoto S,Komatsu H,Ishida T,Inagaki H,Iida S,Kondo Y

    更新日期：2020-08-01 00:00:00

  • Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function.

    abstract：:Loss of von Hippel Lindau (VHL) protein function is a key driver of VHL diseases, including sporadic and inherited clear cell renal cell carcinoma. Modulation of the proteostasis of VHL, especially missense point-mutated VHL, is a promising approach to augmenting VHL levels and function. VHL proteostasis is regulated ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2016.40

    authors： German P,Bai S,Liu XD,Sun M,Zhou L,Kalra S,Zhang X,Minelli R,Scott KL,Mills GB,Jonasch E,Ding Z

    更新日期：2016-09-22 00:00:00

  • Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38.

    abstract：:TSC1 and TSC2 are responsible for the tumor suppressor gene syndrome tuberous sclerosis (TSC). Mammalian TSC genes have been shown to be involved in cell cycle regulation. Recently, in Drosophila, these data have been confirmed and TSC genes have further been demonstrated to affect cell size control. Here we provide s...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1206776

    authors： Rosner M,Hofer K,Kubista M,Hengstschläger M

    更新日期：2003-07-31 00:00:00

  • Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells.

    abstract：:We show that expression of the microtubule depolymerizing kinesin KIF2C is induced by transformation of immortalized human bronchial epithelial cells (HBEC) by expression of K-Ras(G12V) and knockdown of p53. Further investigation demonstrates that this is due to the K-Ras/ERK1/2 MAPK pathway, as loss of p53 had little...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2013.486

    authors： Zaganjor E,Osborne JK,Weil LM,Diaz-Martinez LA,Gonzales JX,Singel SM,Larsen JE,Girard L,Minna JD,Cobb MH

    更新日期：2014-11-20 00:00:00

  • Cellular immune response to HTLV-1.

    abstract：:There is strong evidence at the individual level and the population level that an efficient cytotoxic T lymphocyte (CTL) response to HTLV-1 limits the proviral load and the risk of associated inflammatory diseases such as HAM/TSP. This evidence comes from host population genetics, viral genetics, DNA expression microa...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/sj.onc.1208970

    authors： Bangham CR,Osame M

    更新日期：2005-09-05 00:00:00

  • Cancer whole-genome sequencing: present and future.

    abstract：:Recent explosive advances in next-generation sequencing technology and computational approaches to massive data enable us to analyze a number of cancer genome profiles by whole-genome sequencing (WGS). To explore cancer genomic alterations and their diversity comprehensively, global and local cancer genome-sequencing ...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/onc.2015.90

    authors： Nakagawa H,Wardell CP,Furuta M,Taniguchi H,Fujimoto A

    更新日期：2015-12-03 00:00:00

  • The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair.

    abstract：:Loss of the DNA mismatch repair (MMR) protein MSH3 leads to the development of a variety of tumors in mice without significantly affecting survival rates, suggesting a modulating role for the MutSβ (MSH2-MSH3) complex in late-onset tumorigenesis. To better study the role of MSH3 in tumor progression, we crossed Msh3(-...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2013.365

    authors： van Oers JM,Edwards Y,Chahwan R,Zhang W,Smith C,Pechuan X,Schaetzlein S,Jin B,Wang Y,Bergman A,Scharff MD,Edelmann W

    更新日期：2014-07-24 00:00:00

  • Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.

    abstract：:Next-generation sequencing (NGS) technology has demonstrated that the cancer genomes are peppered with mutations. Although most somatic tumour mutations are unlikely to have any role in the cancer process per se, the spectra of DNA sequence changes in tumour mutation catalogues have the potential to identify the mutag...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/onc.2016.192

    authors： Hollstein M,Alexandrov LB,Wild CP,Ardin M,Zavadil J

    更新日期：2017-01-12 00:00:00

  • Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice.

    abstract：:Pharmacological inactivation of cancer genes or products is being used as a strategy for therapy in oncology. To investigate the potential role of BCR-ABLp190 cessation in leukaemia development, we generated mice carrying a tetracycline-repressible BCR-ABLp190 transgene. These mice were morphologically normal at birth...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1209968

    authors： Pérez-Caro M,Gutierrez-Cianca N,González-Herrero I,López-Hernández I,Flores T,Orfao A,Sánchez-Martín M,Gutiérrez-Adán A,Pintado B,Sánchez-García I

    更新日期：2007-03-15 00:00:00

  • GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest.

    abstract：:Guanine nucleotide binding protein-like 3-like (GNL3L) is a nucleolar protein and the vertebrate paralogue of nucleostemin (NS). We previously reported that nucleoplasmic mobilization of NS stabilizes MDM2 (mouse double minute 2). Here, we investigated the role of GNL3L as a novel MDM2 regulator. We found that GNL3L b...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2010.550

    authors： Meng L,Hsu JK,Tsai RY

    更新日期：2011-04-07 00:00:00

  • Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer.

    abstract：:Chemoprevention has been widely explored as a promising strategy for controlling the incidence of lung cancer, the leading cause of cancer-related death. To maximize the benefit of lung cancer chemoprevention, it is important to identify individuals at high risk for the disease. The genetic background has been shown t...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1206852

    authors： Wang L,Soria JC,Chang YS,Lee HY,Wei Q,Mao L

    更新日期：2003-10-16 00:00:00

  • Cloning of the human Gfi-1 gene and its mapping to chromosome region 1p22.

    abstract：:Recently the rat and mouse Growth Factor Independence (Gfi-1) genes have been cloned (Gilks et al., 1993; Zoring et al; 1996). This gene allows cells in culture to overcome the depletion of growth factors in the culture medium and maintain their proliferative potential. As part of a cloning strategy to isolated genes ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1200910

    authors： Roberts T,Cowell JK

    更新日期：1997-02-27 00:00:00

  • Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.

    abstract：:Human telomerase is a unique reverse transcriptase that is expressed in multiple cancers, but not in the vast majority of normal cells. The enzyme is responsible for telomere protection and maintenance, and supports the proliferative immortality of cancer cells. Thus, it has been proposed that the specific inhibition ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1205064

    authors： Herbert BS,Pongracz K,Shay JW,Gryaznov SM

    更新日期：2002-01-21 00:00:00

  • Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.

    abstract：:Ovarian cancer (OvCa) is characterized by widespread and rapid metastasis in the peritoneal cavity. Visceral adipocytes promote this process by providing fatty acids (FAs) for tumour growth. However, the exact mechanism of FA transfer from adipocytes to cancer cells remains unknown. This study shows that OvCa cells co...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-017-0093-z

    authors： Ladanyi A,Mukherjee A,Kenny HA,Johnson A,Mitra AK,Sundaresan S,Nieman KM,Pascual G,Benitah SA,Montag A,Yamada SD,Abumrad NA,Lengyel E

    更新日期：2018-04-01 00:00:00

  • Mysterious liaisons: the relationship between c-Myc and the cell cycle.

    abstract：:A large body of physiological evidence shows that either upregulation or downregulation of intracellular c-Myc activity has profound consequences on cell cycle progression. Recent work suggests that c-Myc may stimulate the activity of cyclin E/cyclin-dependent kinase 2 (Cdk2) complexes and antagonize the action of the...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/sj.onc.1202749

    authors： Obaya AJ,Mateyak MK,Sedivy JM

    更新日期：1999-05-13 00:00:00

  • Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.

    abstract：:Glioblastoma (GBM) is a highly malignant glioma, which has the propensity to infiltrate throughout the brain in contrast to pilocytic astrocytoma (PA) of the posterior fossa, which does not spread and can be cured by surgery. We have used Suppression Subtractive Hybridization to define markers that better delineate th...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1209305

    authors： Colin C,Baeza N,Bartoli C,Fina F,Eudes N,Nanni I,Martin PM,Ouafik L,Figarella-Branger D

    更新日期：2006-05-04 00:00:00

  • Infrequent alteration of the c-myc gene in human glial tumours associated with increased numbers of c-myc positive cells.

    abstract：:Twenty five human glial tumours of different grades of malignancy were examined by Southern blotting and polymerase chain reaction (PCR) for alterations (rearrangements, amplification and deletions) in the c-myc gene. Number of c-myc positive cells per thousand cells were also counted in all the tumours after immunohi...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Chattopadhyay P,Banerjee M,Sarkar C,Mathur M,Mohapatra AK,Sinha S

    更新日期：1995-12-21 00:00:00

  • Random mutagenesis of PDZ(Omi) domain and selection of mutants that specifically bind the Myc proto-oncogene and induce apoptosis.

    abstract：:Omi is a mammalian serine protease that is localized in the mitochondria and released to the cytoplasm in response to apoptotic stimuli. Omi induces cell death in a caspase-dependent manner by interacting with the X-chromosome linked inhibitor of apoptosis protein, as well as in a caspase-independent way that relies o...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1206359

    authors： Junqueira D,Cilenti L,Musumeci L,Sedivy JM,Zervos AS

    更新日期：2003-05-08 00:00:00

  • Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.

    abstract：:Although it has been demonstrated that transformed progenitor cell population can contribute to tumor initiation, factors contributing to this malignant transformation are poorly known. Using in vitro and xenograft-based models, previous studies demonstrated that miR-489 acts as a tumor suppressor miRNA by targeting v...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/s41388-018-0439-1

    authors： Patel Y,Soni M,Awgulewitsch A,Kern MJ,Liu S,Shah N,Singh UP,Chen H

    更新日期：2019-01-01 00:00:00

  • The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model.

    abstract：:Sequence-specific transcriptional regulators function by stably binding cognate DNA sequences followed by recruitment of both general and specialized factors to target gene promoters. The tumor suppressor p53 mediates its anti-oncogenic effect on cells by functioning as a sequence-specific regulator. p53 employs a sec...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210935

    authors： Balakrishnan SK,Gross DS

    更新日期：2008-04-24 00:00:00

  • Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

    abstract：:The p53 gene has been implicated as a tumor suppressor gene with mutations found in common human cancers. We examined 51 early stage, primary, resected non-small cell lung cancer specimens using an RNAase protection assay and cDNA sequencing. Mutations changing the p53 coding sequence were found in 23/51 (45%) tumor s...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Chiba I,Takahashi T,Nau MM,D'Amico D,Curiel DT,Mitsudomi T,Buchhagen DL,Carbone D,Piantadosi S,Koga H

    更新日期：1990-10-01 00:00:00

  • Apoptosis and melanoma chemoresistance.

    abstract：:Melanoma is the most aggressive form of skin cancer and is notoriously resistant to all current modalities of cancer therapy. A large set of genetic, functional and biochemical studies suggest that melanoma cells become 'bullet proof' against a variety of chemotherapeutic drugs by exploiting their intrinsic resistance...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/sj.onc.1206454

    authors： Soengas MS,Lowe SW

    更新日期：2003-05-19 00:00:00

  • Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct SH2-domain protein binding.

    abstract：:Endothelial cells expressing fibroblast growth factor receptor-1 (FGFR-1) migrate and proliferate in response to treatment with FGF. We analysed ligand-induced migration and proliferation of porcine aortic endothelial cells expressing wild-type FGFR-1, point-mutated Y766F FGFR-1, unable to activate phospholipase C-gam...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1201936

    authors： Landgren E,Klint P,Yokote K,Claesson-Welsh L

    更新日期：1998-07-23 00:00:00

  • Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.

    abstract：:Ataxia-Telangiectasia (A-T) is an autosomal recessive human disease characterized by genetic instability, radiosensitivity, immunodeficiency and cancer predisposition, because of mutation in both alleles of the ATM (ataxia-telangiectasia mutated) gene. The role of Atm heterozygosity in cancer susceptibility is controv...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2008.280

    authors： Mao JH,Wu D,DelRosario R,Castellanos A,Balmain A,Perez-Losada J

    更新日期：2008-11-20 00:00:00

  • RARgamma acts as a tumor suppressor in mouse keratinocytes.

    abstract：:All-trans retinoic acid (RA), the principle biologically active form of vitamin A, is essential for many developmental process as well as homeostasis in the adult. Many lines of evidence also suggest that RA, acting through the RA receptors (RARs), can also suppress growth of tumors of diverse origin. To assess direct...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1207682

    authors： Chen CF,Goyette P,Lohnes D

    更新日期：2004-07-08 00:00:00

  • 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma.

    abstract：:Despite extensive characterization of the role of the EWS-ETS fusions, little is known about secondary genetic alterations and their clinical contribution to Ewing sarcoma (ES). It has been demonstrated that the molecular structure of EWS-ETS lacks prognostic value. Moreover, CDKN2A deletion and TP53 mutation, despite...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2011.317

    authors： Mackintosh C,Ordóñez JL,García-Domínguez DJ,Sevillano V,Llombart-Bosch A,Szuhai K,Scotlandi K,Alberghini M,Sciot R,Sinnaeve F,Hogendoorn PC,Picci P,Knuutila S,Dirksen U,Debiec-Rychter M,Schaefer KL,de Álava E

    更新日期：2012-03-08 00:00:00